These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5417676)

  • 1. [SH antigen in patients undergoing long-term extracorporal dialysis. Cross-sectional study in five German centers for hemodialysis].
    Sanwald R; Ritz E; Rapp W; Andrassy K; Kommerell B
    Dtsch Med Wochenschr; 1970 Feb; 95(6):253-6. PubMed ID: 5417676
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endemia of Australia (SH) antigen-positive hepatitis in a dialysis center].
    Kaboth U; Schober A; Klinge O; Lowitz HD; Quellhorst E; Scheler F; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Jul; 96(30):1235-42. PubMed ID: 4997734
    [No Abstract]   [Full Text] [Related]  

  • 3. [Australia-SH antigen in patients undergoing hemodialysis].
    Kommerell B; Sanwald R; Ritz E; Andrassy K; Rapp W
    Bibl Haematol; 1971; 37():243-4. PubMed ID: 5138910
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus infection in hemodialysis: recent discoveries.
    Fabrizi F; Lunghi G; Martin P
    J Nephrol; 2002; 15(5):463-8. PubMed ID: 12455711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frequency of hepatitis, HBs-antigen and anti-HBs frequency in patients at the Heidelberg hemodialysis center].
    Schimpf Kl; Zimmermann K; Thamer G; Rüdel J
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():414-7. PubMed ID: 1029227
    [No Abstract]   [Full Text] [Related]  

  • 7. Outbreaks of hepatitis B virus infection among hemodialysis patients-- California, Nebraska, and Texas, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Apr; 45(14):285-9. PubMed ID: 8598825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Markers of viral replication (HBeAg and DNA polymerase activity) in chronic uremia, HBsAg positive, hemodialysis patients].
    Dentico P; Buongiorno R; Angarano G; Monno L; Coppola S; Laddago V; Spinelli A; Pastore G
    Boll Soc Ital Biol Sper; 1980 Nov; 56(21):2193-9. PubMed ID: 7213481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National surveillance of dialysis associated diseases in the United States, 1992.
    Tokars JI; Alter MJ; Favero MS; Moyer LA; Miller E; Bland LA
    ASAIO J; 1994; 40(4):1020-31. PubMed ID: 7858322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National surveillance of dialysis associated diseases in the United States, 1993.
    Tokars JI; Alter MJ; Favero MS; Moyer LA; Miller E; Bland LA
    ASAIO J; 1996; 42(3):219-29. PubMed ID: 8725695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum hepatitis and hemodialysis. Australia antigen in patients and personnel of a dialysis center].
    Berthold H; Heinze V; Vonend E
    Anglo Ger Med Rev; 1972 Mar; 6(3):137-41. PubMed ID: 4655634
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
    Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incidence of viral hepatitis in centers for hemodialysis].
    Seidlová V; Raska P; Vrublovský P; Jezdinská V; Pelikán V
    Vnitr Lek; 1972 Nov; 18(11):1042-51. PubMed ID: 4634652
    [No Abstract]   [Full Text] [Related]  

  • 14. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Australia antigen in chronic hemodialysis.
    Andrassy K; Ritz E; Sanwald R
    Vox Sang; 1970; 19(3):369-70. PubMed ID: 4926157
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatitis B in a hemodialysis unit].
    Pedreira JD; Olmos Miro A; Guardia J; Radriquez Hermandez JA; Martinez-Vazquez JM; Piera Robert L; Bacardi R
    Rev Clin Esp; 1976 Dec; 143(5):. PubMed ID: 1005822
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].
    Fabrizi F; Bisegna S; Mangano S; Alongi G; Colucci P; Finazzi S; De Vecchi AF; Ponticelli C
    G Ital Nefrol; 2002; 19(2):149-54. PubMed ID: 12195413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Decrease of transfusion hepatitis following introduction of transaminases and Australia (SH)-antigen determination in blood donors].
    Arndt HJ; Frese R; Nachtwey K; Loos W; Kaboth U; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Aug; 96(34):1371-2. PubMed ID: 4998053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Viral hepatitis and Au antigen in the Dialysis Centers].
    Bonomini V; Mioli V
    Bull Sci Med (Bologna); 1971; 143(2):87-93. PubMed ID: 5113532
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.